We are live on
!
Find out more
ADIM
Alpha DNA Investment Management Portfolio holdings
AUM
$8.98M
1-Year Est. Return
26.05%
This Fund
S&P 500
This Quarter
Est. Return
+14.27%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$256M
AUM Growth
+$12.2M
(+5%)
Cap. Flow
-$14.2M
Cap. Flow
% of AUM
-5.52%
Top 10 Holdings %
Top 10 Hldgs %
47.16%
Holding
248
New
79
Increased
35
Reduced
67
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.6M |
| 2 |
EOG Resources
EOG
|
+$2.56M |
| 3 |
Chevron
CVX
|
+$2.51M |
| 4 |
Kenvue
KVUE
|
+$1.8M |
| 5 |
NextEra Energy
NEE
|
+$1.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$3M |
| 2 |
PPG Industries
PPG
|
+$2.06M |
| 3 |
Colgate-Palmolive
CL
|
+$1.74M |
| 4 |
McDonald's
MCD
|
+$1.67M |
| 5 |
RTX Corp
RTX
|
+$1.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.66% |
| 2 | Financials | 12.3% |
| 3 | Healthcare | 9.54% |
| 4 | Energy | 5.49% |
| 5 | Consumer Staples | 5.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRNS
101
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $540K | 0.21% |
49,664
-27,419
| -36% | -$205K |
|
102
A.O. Smith
AOS
$8.65B
| $539K | 0.21% |
+6,533
| New | +$482K |
|
103
Sixth Street Specialty
TSLX
$1.78B
| $538K | 0.21% |
24,903
-2,723
| -10% | -$55.9K |
|
104
Duolingo
DUOL
$6.34B
| $538K | 0.21% |
+2,371
| New | +$461K |
|
105
Woodward
WWD
$21.1B
| $537K | 0.21% |
3,946
-229
| -5% | -$29.9K |
|
|
BECN
106
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $536K | 0.21% |
+6,159
| New | +$483K |
|
107
Wintrust Financial
WTFC
$10.9B
| $534K | 0.21% |
+5,760
| New | +$476K |
|
108
Customers Bancorp
CUBI
$2.8B
| $534K | 0.21% |
9,260
-6,617
| -42% | -$287K |
|
109
City Holding Co
CHCO
$2.06B
| $531K | 0.21% |
+4,820
| New | +$472K |
|
110
Roku
ROKU
$22.4B
| $531K | 0.21% |
+5,795
| New | +$485K |
|
111
RxSight
RXST
$293M
| $531K | 0.21% |
13,165
-7,714
| -37% | -$226K |
|
112
Vivid Seats
SEAT
$84.4M
| $531K | 0.21% |
+4,198
| New | +$575K |
|
113
Wingstop
WING
$3.03B
| $530K | 0.21% |
+2,064
| New | +$446K |
|
114
Peoples Bancorp
PEBO
$1.47B
| $526K | 0.21% |
+15,571
| New | +$454K |
|
115
Skyward Specialty Insurance
SKWD
$2.5B
| $525K | 0.2% |
+15,497
| New | +$477K |
|
|
PXD
116
DELISTED
Pioneer Natural Resource Co.
PXD
| $523K | 0.2% |
2,327
-947
| -29% | -$222K |
|
117
Trinity Industries
TRN
$2.29B
| $523K | 0.2% |
+19,669
| New | +$473K |
|
118
Nutanix
NTNX
$17.4B
| $522K | 0.2% |
10,944
-5,053
| -32% | -$204K |
|
119
Five Below
FIVE
$13B
| $521K | 0.2% |
+2,444
| New | +$449K |
|
120
Acadia Pharmaceuticals
ACAD
$5.07B
| $517K | 0.2% |
+16,510
| New | +$394K |
|
121
Camtek
CAMT
$7.67B
| $509K | 0.2% |
7,343
-1,864
| -20% | -$113K |
|
122
Lennar Class A
LEN
$21.1B
| $505K | 0.2% |
3,497
-6,381
| -65% | -$769K |
|
123
GitLab
GTLB
$7.11B
| $502K | 0.2% |
+7,968
| New | +$403K |
|
124
Ambarella
AMBA
$3.64B
| $501K | 0.2% |
+8,182
| New | +$447K |
|
125
lululemon athletica
LULU
$14.3B
| $501K | 0.2% |
979
+382
| +64% | +$165K |
|
Similar funds
CAWM
AI
PC
CP
AVM
CSD
NP
BPWM
Alpha DNA Investment Management's Q4 2023 Portfolio in Review
As of Q4 2023, Alpha DNA Investment Management held 248 positions worth $256M, up 5% from $244M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Alpha DNA Investment Management withdrew a net $14.2M in Q4 2023, closing 65 positions and reducing 67 holdings. Its most notable exit was Eli Lilly, an estimated $3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Alpha DNA Investment Management opened a new position in Kenvue worth $1.93M.
- Alpha DNA Investment Management's largest Q4 2023 buy was Kenvue: 89,868 shares worth $1.93M.
- Alpha DNA Investment Management added most to Microsoft in Q4 2023, an estimated $2.6M increase.
- Alpha DNA Investment Management's biggest Q4 2023 reduction was PPG Industries, cutting an estimated $2.06M.
- Alpha DNA Investment Management fully exited Eli Lilly in Q4 2023, selling an estimated $3M.
- Alpha DNA Investment Management's ten largest holdings make up 47% of its $256M portfolio in Q4 2023.
- Alpha DNA Investment Management opened 79 new positions and closed 65 in Q4 2023.
- Alpha DNA Investment Management's portfolio value rose 5% quarter-over-quarter to $256M.
Based on Alpha DNA Investment Management's 13F filing for Q4 2023, filed 12 Feb 2024.